Search

Displaying results 6251 - 6260 of 10000 in total
  1. Drug

    Inakalant

    go.drugbank.com/drugs/DB20424
    Investigational

    Inakalant is under investigation in clinical trial NCT00255281 (Efficacy and Safety of AZD7009 in the Treatment of Atrial Fibrillation). Inakalant has a monoisotopic molecular weight of 446.25 Da. … The usage of the INN stem '-kalant' in the name indicates that Inakalant is a potassium channel blocker.

  2. Drug

    RG2417

    go.drugbank.com/drugs/DB05055
    Investigational

    This new insight suggests that the symptoms of bipolar disorder may be linked to dysregulation of energy metabolism of the brain. … RG2417 is a proprietary formulation of uridine, a biological compound essential for the synthesis of DNA and RNA, the basic hereditary material found in all cells, and numerous other factors essential

  3. Drug

    Carpipramine

    go.drugbank.com/drugs/DB20320
    Experimental

    The usage of the INN stem '-pramine' in the name indicates that Carpipramine is a substance of the imipramine group. Carpipramine has a monoisotopic molecular weight of 446.3 Da.

  4. Drug

    Tienopramine

    go.drugbank.com/drugs/DB19796
    Experimental

    The usage of the INN stem '-pramine' in the name indicates that Tienopramine is a substance of the imipramine group. Tienopramine has a monoisotopic molecular weight of 284.13 Da.

  5. Drug

    Zegruvirimat

    go.drugbank.com/drugs/DB21535
    Experimental

    The usage of the INN stem '-virimat' in the name indicates that Zegruvirimat is a antiviral, disruptor of viral maturation. Zegruvirimat has a monoisotopic molecular weight of 826.51 Da.

  6. Drug

    SR-123781A

    go.drugbank.com/drugs/DB05361
    Investigational

    It is under investigation by Sanofi-Aventis and Organon for the treatment of thrombosis and acute coronary syndromes (ACS).

  7. Drug

    beta-Hydroxybutyric acid

    go.drugbank.com/drugs/DB16506
    Investigational

    Beta-hydroxybutyrate is being studied in around 230 clinical trials, including NCT06351124 (recruiting for Crohn's disease), NCT05584371 (recruiting for safety and tolerability of exogenous ketosis), NCT04656236

  8. Drug

    Vitex agnus-castus fruit extract

    go.drugbank.com/drugs/DB13193
    Investigational

    Clinical studies demonstrates effectiveness of vitex agnus-castus fruit extract in the management of premenstrual stress syndrome (PMS) and cyclical breast pain (mastalgia). … Vitex agnus-castus fruit extract is obtained from dry fruits of Vitex agnus-castus.

  9. Drug

    TOL2

    go.drugbank.com/drugs/DB17918
    Experimental

    TOL2 is a modified form of the acetylcholine receptor being investigated for the treatment of myasthenia gravis.[A260117]

  10. Drug

    ISP-001

    go.drugbank.com/drugs/DB18501
    Investigational

    ISP-001 consists of sleeping beauty transposon-engineered autologous plasmablasts for expression and delivery of alpha-L-iduronidase.